Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bridge To Build Second Beijing Lab | Contract Pharma
Breaking News

Bridge To Build Second Beijing Lab

Bridge Laboratories has reached an agreement to build its second preclinical facility in China. This purpose-built, 150,000-sq.-ft. facility will be adjacent to the company’s existing laboratory in the Zhongguancun Life Science Park located in Beijing. Construction will begin in 4Q08 and is expected to be complete by 4Q09.

The facility is designed to meet FDA and worldwide regulatory standards, and will provide GLP toxicology, immunology, vaccine, and bioanalytical services, according to the company. This new facility will quadruple Bridge’s available laboratory space in Beijing.

“Bridge is committed to providing quality preclinical services to our customers, and this new facility will enable us to expand our ability to deliver U.S.-level regulatory compliant outsourced discovery and development services in a cost effective manner,” said Tom Oakley, president and chief executive officer of Bridge Laboratories.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters